The down-regulation effect of JP on the BAFF/BAFF-R signaling pathway may be an important mechanism in reducing the dosage of GC when they are used in combination to treat SLE; thus, the side effects of GC can be greatly diminished. Here, TNFSF13B is linked to systemic lupus erythematosus.